Can I read Roxadustat Approval & FG-3246 Study Update on EtoBox?

Roxadustat Approval & FG-3246 Study Update by xchen1780 is a document available to read on EtoBox.

What is Roxadustat Approval & FG-3246 Study Update about?

Approval decision for roxadustat is expected in the second half of 2024, with a potential $10 million milestone payment from AstraZeneca upon approval. Additionally, a Phase 2 monotherapy dose optimization study of FG-3246 in mCRPC is anticipated to begin in the second half of 2024.

Author

xchen1780

Language

EN